Valuation Update With 7 Day Price Move • 6h
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to د.أ15.65, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 23x in the Chemicals industry in Asia. Total returns to shareholders of 224% over the past three years. Reported Earnings • May 05
First quarter 2026 earnings released: EPS: د.أ0.37 (vs د.أ0.37 in 1Q 2025) First quarter 2026 results: EPS: د.أ0.37 (up from د.أ0.37 in 1Q 2025). Revenue: د.أ326.5m (up 13% from 1Q 2025). Net income: د.أ110.7m (flat on 1Q 2025). Profit margin: 34% (down from 38% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. 공시 • Apr 03
Jordan Phosphate Mines Co. Plc, Annual General Meeting, Apr 20, 2026 Jordan Phosphate Mines Co. Plc, Annual General Meeting, Apr 20, 2026. Location: amman Jordan Declared Dividend • Apr 01
Dividend of د.أ1.70 announced Shareholders will receive a dividend of د.أ1.70. Ex-date: 21st April 2026 Payment date: 1st January 1970 Dividend yield will be 5.9%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by earnings (71% earnings payout ratio) but not covered by cash flows (109% cash payout ratio). The dividend has increased by an average of 57% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 83% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. 공시 • Mar 31
Jordan Phosphate Mines Co. Plc announces Annual dividend Jordan Phosphate Mines Co. Plc announced Annual dividend of JOD 1.7000 per share, ex-date on April 21, 2026 and record date on April 20, 2026. Board Change • Mar 30
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. 1 independent director (8 non-independent directors). Independent Chairman of the Board Mohammad Mahmoud Al-Thneibat is the most experienced director on the board, commencing their role in 2017. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 01
Second quarter 2025 earnings released: EPS: د.أ0.47 (vs د.أ0.37 in 2Q 2024) Second quarter 2025 results: EPS: د.أ0.47 (up from د.أ0.37 in 2Q 2024). Revenue: د.أ313.8m (up 7.2% from 2Q 2024). Net income: د.أ139.4m (up 26% from 2Q 2024). Profit margin: 44% (up from 38% in 2Q 2024). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to د.أ17.85, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 23x in the Chemicals industry in Asia. Total returns to shareholders of 125% over the past three years. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to د.أ14.73, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 23x in the Chemicals industry in Asia. Total returns to shareholders of 58% over the past three years. Board Change • Apr 03
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 7 non-independent directors. Independent Chairman of the Board Mohammad Mahmoud Al-Thneibat was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 14
Full year 2024 earnings released: EPS: د.أ1.86 (vs د.أ1.80 in FY 2023) Full year 2024 results: EPS: د.أ1.86 (up from د.أ1.80 in FY 2023). Revenue: د.أ1.21b (down 1.3% from FY 2023). Net income: د.أ459.3m (up 3.1% from FY 2023). Profit margin: 38% (up from 36% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings. Reported Earnings • Oct 29
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: د.أ306.1m (up 6.7% from 3Q 2023). Net income: د.أ113.7m (up 3.0% from 3Q 2023). Profit margin: 37% (down from 39% in 3Q 2023). The decrease in margin was driven by higher expenses. Reported Earnings • Apr 06
Full year 2023 earnings released Full year 2023 results: Revenue: د.أ1.23b (down 30% from FY 2022). Net income: د.أ445.5m (down 38% from FY 2022). Profit margin: 36% (down from 41% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 55% per year whereas the company’s share price has increased by 59% per year. Reported Earnings • Nov 03
Third quarter 2023 earnings released: EPS: د.أ0.45 (vs د.أ0.92 in 3Q 2022) Third quarter 2023 results: EPS: د.أ0.45 (down from د.أ0.92 in 3Q 2022). Revenue: د.أ286.9m (down 44% from 3Q 2022). Net income: د.أ110.5m (down 52% from 3Q 2022). Profit margin: 39% (down from 44% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 9.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Asia are expected to grow by 12%. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has increased by 135% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Aug 25
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 34% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 34% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Aug 02
Second quarter 2023 earnings released: EPS: د.أ0.45 (vs د.أ0.90 in 2Q 2022) Second quarter 2023 results: EPS: د.أ0.45 (down from د.أ0.90 in 2Q 2022). Revenue: د.أ318.2m (down 40% from 2Q 2022). Net income: د.أ110.7m (down 50% from 2Q 2022). Profit margin: 35% (down from 42% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has increased by 134% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 06
First quarter 2023 earnings released: EPS: د.أ1.25 (vs د.أ1.80 in 1Q 2022) First quarter 2023 results: EPS: د.أ1.25 (down from د.أ1.80 in 1Q 2022). Revenue: د.أ313.6m (down 12% from 1Q 2022). Net income: د.أ103.2m (down 30% from 1Q 2022). Profit margin: 33% (down from 42% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 164% After last week's 164% share price gain to د.أ36.25, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 17x in the Chemicals industry in Asia. Total returns to shareholders of 4,935% over the past three years. Reported Earnings • Mar 30
Full year 2022 earnings released Full year 2022 results: Revenue: د.أ1.75b (up 62% from FY 2021). Net income: د.أ715.4m (up 114% from FY 2021). Profit margin: 41% (up from 31% in FY 2021). The increase in margin was driven by higher revenue. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 2 independent directors (7 non-independent directors). Independent Chairman of the Board Mohammad Mahmoud Al-Thneibat was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • May 01
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: د.أ1.78 (up from د.أ0.43 in 1Q 2021). Revenue: د.أ344.0m (up 87% from 1Q 2021). Net income: د.أ146.5m (up 312% from 1Q 2021). Profit margin: 43% (up from 19% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.6%. Earnings per share (EPS) also surpassed analyst estimates by 29%. Over the next year, revenue is expected to shrink by 13% compared to a 24% growth forecast for the industry in Asia. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has increased by 131% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Apr 27
Price target increased to د.أ22.00 Up from د.أ16.00, the current price target is provided by 1 analyst. New target price is 38% below last closing price of د.أ35.50. Stock is up 297% over the past year. The company is forecast to post earnings per share of د.أ4.06 for next year compared to د.أ4.06 last year. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 2 independent directors (7 non-independent directors). Independent Chairman of the Board Mohammad Mahmoud Al-Thneibat was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improved over the past week After last week's 20% share price gain to د.أ32.95, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Chemicals industry in Asia. Total returns to shareholders of 1,079% over the past three years. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improved over the past week After last week's 18% share price gain to د.أ22.60, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 14x in the Chemicals industry in Asia. Total returns to shareholders of 743% over the past three years. Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment improved over the past week After last week's 16% share price gain to د.أ17.45, the stock trades at a trailing P/E ratio of 49.6x. Average trailing P/E is 15x in the Chemicals industry in Jordan. Total returns to shareholders of 571% over the past three years. Valuation Update With 7 Day Price Move • Aug 08
Investor sentiment deteriorated over the past week After last week's 15% share price decline to د.أ14.56, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 17x in the Chemicals industry in Jordan. Total returns to shareholders of 418% over the past three years. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improved over the past week After last week's 15% share price gain to د.أ14.90, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 418% over the past three years. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 16% share price gain to د.أ12.16, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 15x in the Chemicals industry in Asia. Total returns to shareholders of 318% over the past three years. Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment improved over the past week After last week's 16% share price gain to د.أ8.26, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 17x in the Chemicals industry in Asia. Total returns to shareholders of 199% over the past three years. Is New 90 Day High Low • Mar 01
New 90-day high: د.أ6.57 The company is up 146% from its price of د.أ2.67 on 01 December 2020. The Jordanian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 31% over the same period. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment improved over the past week After last week's 16% share price gain to د.أ5.58, the stock is trading at a trailing P/E ratio of 15.5x, up from the previous P/E ratio of 13.5x. This compares to an average P/E of 18x in the Chemicals industry in Jordan. Total returns to shareholders over the past three years are 104%. Reported Earnings • Feb 17
Full year 2020 earnings released: EPS د.أ0.36 (vs د.أ0.27 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: د.أ606.6m (down 5.3% from FY 2019). Net income: د.أ29.6m (up 36% from FY 2019). Profit margin: 4.9% (up from 3.4% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 08
New 90-day high: د.أ4.51 The company is up 78% from its price of د.أ2.54 on 09 November 2020. The Jordanian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period. Is New 90 Day High Low • Jan 18
New 90-day high: د.أ3.64 The company is up 52% from its price of د.أ2.40 on 20 October 2020. The Jordanian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 10
New 90-day high: د.أ2.79 The company is up 9.0% from its price of د.أ2.55 on 10 September 2020. The Jordanian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 9.0% over the same period. Is New 90 Day High Low • Nov 25
New 90-day high: د.أ2.65 The company is up 2.0% from its price of د.أ2.61 on 27 August 2020. The Jordanian market is flat over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Oct 14
New 90-day low: د.أ2.44 The company is down 8.0% from its price of د.أ2.66 on 16 July 2020. The Jordanian market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.